Muriel Amblard Selected Research

Cathepsin D

10/2013

Dipeptide mimic oligomer transporter mediates intracellular delivery of Cathepsin D inhibitors: a potential target for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muriel Amblard Research Topics

Disease

3	Neoplasms (Cancer) 06/2023 - 10/2013
1	COVID-19 06/2023
1	Hypertension (High Blood Pressure) 06/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Osteoarthritis 06/2021
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Edema (Dropsy) 04/2009
1	Inflammation (Inflammations) 04/2009
1	Pain (Aches) 04/2009

Drug/Important Bio-Agent (IBA)

2	JMV4463IBA 02/2016 - 10/2013
2	pepstatin (pepstatin A)IBA 02/2016 - 10/2013
1	nirmatrelvirIBA 06/2023
1	Peptide Hydrolases (Proteases)FDA Link 06/2023
1	Proprotein Convertase 9IBA 12/2021
1	LDL Receptors (LDL Receptor)IBA 12/2021
1	CollagenIBA 06/2021
1	abemaciclibIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Cyclin DIBA 01/2020
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 02/2016
1	statineIBA 02/2016
1	Aspartic Acid ProteasesIBA 10/2013
1	Cathepsin DIBA 10/2013
1	DipeptidesIBA 10/2013
1	BradykininIBA 04/2009

Therapy/Procedure

2	Therapeutics 01/2020 - 10/2013